Delivery Order SPE2DB22D2206-SPE2DB25FFT80
Award Date
2/21/25
Potential Completion Date
2/24/25
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. The contract has a firm fixed price of $2,197.83 and a period of performance through August 14, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a wide range of...
This federal contract award, valued at $7,695.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the provision of RAMELTEON 8 MG TABLET UD 50S, with an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, valued at $1,628.98, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RAMELTEON 8 MG TABLET UD 50S, a generic pharmaceutical product, with a period of performance through May 14, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,347.17, is a Delivery Order to supply RAMELTEON 8 MG TABLET UD 50S, a generic medication. The contract has an ultimate completion date of December 1, 2023 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
This federal contract award, SPE2DB20D1100|SPE2DB25FZ68D, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of RAMELTEON 8 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price of $1,061.28 and a completion date of December 20, 2024. This is a delivery order contract, and no set-aside designation was used. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,496.95 firm-fixed-price delivery order is for the supply of 4565439755 RAMELTEON 8 MG TABLET UD 50S, a prescription medication. The award has an ultimate completion date of August 14, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including...
This is a Delivery Order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) with a Ceiling Value of $1,723.77. The contract is for the provision of Ramelteon 8 mg Tablets in quantities of 100s. The contract has a period of performance through June 28, 2024 and is a Firm Fixed Price contract. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
This delivery order was awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of RAMELTEON 8 MG TABLET 30S, a pharmaceutical product. The order is valued at $1,153.53 and has a completion date of September 24, 2024. It is a firm fixed-price contract without a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, leveraging its extensive supply...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,669.96 firm-fixed-price delivery order is for the supply of 100 count bottles of the medication Ramelteon 8 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $5,228.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of Ramelteon 8 mg Tablet UD 50s, with a completion date of February 6, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...